Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Sell
45
ROP Quote, Financials, Valuation and Earnings
Last price:
$522.31
Seasonality move
:
7.42%
Day range:
$515.81 - $520.20
52-week range:
$499.47 - $580.09
Dividend yield:
0.59%
P/E ratio:
37.97x
P/S ratio:
8.27x
P/B ratio:
3.01x
Volume:
619.7K
Avg. volume:
641.8K
1-year change:
-3.38%
Market cap:
$55.7B
Revenue:
$6.2B
EPS (TTM):
$13.67
Analysts' Opinion
-
Consensus RatingRoper Technologies has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 7 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $611.95, Roper Technologies has an estimated upside of 17.89% from its current price of $519.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $490.00 representing 5.61% downside risk from its current price of $519.10.
Fair Value
-
According to the consensus of 14 analysts, Roper Technologies has 17.89% upside to fair value with a price target of $611.95 per share.
ROP vs. S&P 500
-
Over the past 5 trading days, Roper Technologies has underperformed the S&P 500 by -0.17% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Roper Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Roper Technologies has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Roper Technologies reported revenues of $1.8B.
Earnings Growth
-
Roper Technologies has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Roper Technologies reported earnings per share of $3.40.
Enterprise value:
63.8B
EV / Invested capital:
--
Price / LTM sales:
8.27x
EV / EBIT:
30.49x
EV / Revenue:
9.41x
PEG ratio (5yr expected):
--
EV / Free cash flow:
29.27x
Price / Operating cash flow:
25.71x
Enterprise value / EBITDA:
22.07x
Gross Profit (TTM):
$4.7B
Return On Assets:
5%
Net Income Margin (TTM):
21.78%
Return On Equity:
8.3%
Return On Invested Capital:
5.87%
Operating Margin:
28.14%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $5.2B | $6B | $6.8B | $1.6B | $1.8B | |
| Gross Profit | $3.6B | $4.2B | $4.7B | $1.1B | $1.2B | |
| Operating Income | $1.5B | $1.7B | $1.9B | $446.1M | $496.6M | |
| EBITDA | $2B | $2.5B | $2.9B | $676.2M | $740.9M | |
| Diluted EPS | $27.22 | $27.34 | $13.67 | $3.23 | $3.40 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.7B | $2.4B | $4B | $1.5B | $1.6B | |
| Total Assets | $23.7B | $23.7B | $24.4B | $28.2B | $31.6B | |
| Current Liabilities | $2.3B | $2.9B | $2.8B | $2.8B | $3.3B | |
| Total Liabilities | $13.5B | $12.4B | $10.5B | $11.1B | $13B | |
| Total Equity | $10.2B | $11.3B | $13.9B | $17B | $18.5B | |
| Total Debt | $9.7B | $8.3B | $6.7B | $6.9B | $8.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2B | $1.5B | $2.3B | $630M | $755.4M | |
| Cash From Investing | $2.3B | -$3.2B | -$3.6B | -$2B | -$1.6B | |
| Cash From Financing | -$1.9B | $51.1M | $1.3B | $179.1M | $886.3M | |
| Free Cash Flow | $1.2B | $1.4B | $2.2B | $607.7M | $719.2M | |
ROP
Sector
Market Cap
$55.7B
$115.1M
Price % of 52-Week High
89.49%
67.62%
Dividend Yield
0.59%
0%
Shareholder Yield
-0.08%
0.91%
1-Year Price Total Return
-3.38%
-5.01%
Beta (5-Year)
1.041
0.916
Dividend yield:
0.59%
Annualized payout:
$2.73
Payout ratio:
21.26%
Growth streak:
10 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$510.37
200-day SMA
Sell
Level
$544.16
Bollinger Bands (100)
Sell
Level
529.82 - 562.18
Chaikin Money Flow
Buy
Level
149.2M
20-day SMA
Buy
Level
$518.30
Relative Strength Index (RSI14)
Sell
Level
44.68
ADX Line
Sell
Level
45.56
Williams %R
Neutral
Level
-32.5082
50-day SMA
Sell
Level
$541.67
MACD (12, 26)
Sell
Level
-8.59
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
152.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.3772)
Buy
CA Score
(Annual)
Level (0.426)
Buy
Beneish M-Score
(Annual)
Level (-2.4365)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.5342)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Roper Technologies is a diversified technology company that operates three segments: application software, network software, and technology enabled products. Roper acquires asset light, cash generative businesses and deploys excess cash to acquire further portfolio companies. The firm operates a highly decentralized model with portfolio company management holding autonomy and accountability for key operational decisions, and a small, centralized team overseeing capital deployment and providing executive coaching and reviewing strategic goals.
Stock Forecast FAQ
In the current month, ROP has received 7 Buy ratings 7 Hold ratings, and 0 Sell ratings. The ROP average analyst price target in the past 3 months is $611.95.
-
Where Will Roper Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Roper Technologies share price will rise to $611.95 per share over the next 12 months.
-
What Do Analysts Say About Roper Technologies?
Analysts are divided on their view about Roper Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Roper Technologies is a Sell and believe this share price will drop from its current level to $490.00.
-
What Is Roper Technologies's Price Target?
The price target for Roper Technologies over the next 1-year time period is forecast to be $611.95 according to 14 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is ROP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Roper Technologies is a Leans Bullish. 7 of 14 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of ROP?
You can purchase shares of Roper Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Roper Technologies shares.
-
What Is The Roper Technologies Share Price Today?
Roper Technologies was last trading at $522.31 per share. This represents the most recent stock quote for Roper Technologies. Yesterday, Roper Technologies closed at $519.10 per share.
-
How To Buy Roper Technologies Stock Online?
In order to purchase Roper Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
Sell
34
NGVT alert for Jan 17
Ingevity [NGVT] is up 1.31% over the past day.
